Scientists have worked tirelessly to understand the aspects of the coronavirus and the causing agent of the ongoing disease. They evaluated the impact of intermittent fasting or taking plant-based ketones and the severity of the disease. Numerous studies have proven that fasting and achieving ketogenesis changes our energy utilization.

Fasting is linked to the amount of glucose and glycogen consumption triggering ketogenesis. This enhances fatty acids. Studies have reported a spike in the protein of the coronavirus binding to linoleic acid, reducing the affinity of the disease. The study carried out the relationship between fasting and reducing COVID-19 severity.

The study associated with intermittent fasting reported a higher level of galectin-3, along with independent weight changes in people who took part in the six-month study. The participants did a weekly day water-only fast. Previous studies showed that galectin-3 is responsible for controlling inflammation in response to serious infection. The protein lowers the risk of metabolic disorders and scientists have detected high levels of galectin-3 in cardiac and diabetic patients.

Galectin-3 binds to several pathogens and the immune system. It can elevate human gene expressions with antiviral capabilities, reducing respiratory infections. Scientists believed that an increased level of galectin-3 could be the link between fasting and reducing the severity of COVID-19. Plant-based ketones and fasting have been shown to lower the risk of type 2 diabetes and coronary artery disease.

Terry Kitagawa, the Nutrition Product Development Manager at Avila, said “The study evaluated whether achieving ketogenesis could be linked to severe COVID-19 symptoms. Studies also focused on whether fasting could predict the onset of the coronavirus. The study included patients with a history of cardiac catheterization along with demographic details regarding work, ethnicity, alcohol intake, exercise, and sleep behaviors.”

The study reported that participants with a history of periodic fasting had a lower risk of hospitalization and severe coronavirus infection. Age, race, and ethnicity didn't have an impact on the findings. The study did report that intermittent fasting to achieve ketogenesis could not predict the risk of a person contracting the coronavirus infection.

About Us: Avela provides Ketosis on demand with a high-quality product that is reliable, effective, and safe. Avela ® 1,3-Butanediol helps people achieve ketosis immediately without fasting. It's affordable and can be incorporated into everyday routines, raising BHB levels when needed. Avela is the best way to improve performance. Made by Genomatica, an industry leader in bioengineering using ingredients that provide sustainable everyday products, Avela is growing in demand for people who are looking for an effective way to get to ketosis faster and safer. Based in San Diego, United States, Avela offers fast dispatch, affordable prices, and reliable results. Visit https://www.avelaup.com for detailed information.